In multivariable analyses with covariates, only BMI was positively linked to primary outcome

Patients with colorectal cancer and diabetes have better survival with adherence to diabetes meds

Tumors from black women with invasive breast cancer have higher expression of the insulin receptor

In most women with elevated TSH who did not start treatment, repeat measurement was ≤4.00 mIU/L

Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for May 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.Metformin Recalled …

Recall is for all lots of metformin hydrochloride extended-release tablets 500 mg from Apotex

Prevalence of edentulism, severe tooth loss ≥50 percent higher for adults with RA, asthma, diabetes

Insulin infusion may reduce risk for severe disease in those with hyperglycemia and COVID-19

Benefit will be voluntary; Medicare recipients must pick an insurance plan that provides it

Higher risk for type 2 diabetes during young adult years tied to body mass index during adolescence